Maraviroc and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Maraviroc (maraviroc), especially for people who are male, 40-49 old, also take Isentress, and have Hiv infection.

The phase IV clinical study analyzes which people have Stroke when taking Maraviroc. It is created by eHealthMe based on reports of 2,652 people who have side effects when taking Maraviroc from the FDA, and is updated regularly.

What is Maraviroc?

Maraviroc has active ingredients of maraviroc. eHealthMe is studying from 2,653 Maraviroc users. Check the latest studies of Maraviroc.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,309 drugs and 3,030 conditions by eHealthMe. Check the latest studies of Stroke.

On Jul, 22, 2026

2,652 people reported to have side effects when taking Maraviroc.
Among them, 11 people (0.41%) have Stroke.

Among these 11 people:

What is the gender of people who have Stroke when taking Maraviroc? *

female: 36.36 %
male: 63.64 %

What is the age of people who have Stroke when taking Maraviroc? *

What are other drugs people take besides Maraviroc? *

Isentress: 5 people, 45.45%
Clonazepam: 4 people, 36.36%
Rosuvastatin Calcium: 4 people, 36.36%
Clopidogrel Bisulfate: 4 people, 36.36%
Escitalopram Oxalate: 4 people, 36.36%
Oxazepam: 4 people, 36.36%
Emtricitabine And Tenofovir Disoproxil Fumarate: 4 people, 36.36%
Amlodipine Besylate: 4 people, 36.36%
Sotalol Hydrochloride: 4 people, 36.36%
Tramadol Hydrochloride: 4 people, 36.36%

What are other side effects people have besides Stroke? *

Thrombocytopenia (decrease of platelets in blood): 1 person, 9.09%
Plasmablastic Lymphoma (aggressive b-cell cancer occurring mainly in the jaws and oral cavity): 1 person, 9.09%
Nosebleed (bleeding from nose): 1 person, 9.09%
Microcytic Anaemia (a generic term for any type of anaemia characterized by small red blood cells): 1 person, 9.09%
Lung Disorder (lung disease): 1 person, 9.09%
Hypovolaemic Shock (shock caused by severe blood or fluid loss): 1 person, 9.09%
Hypovolaemia (a decreased volume of circulating blood in the body): 1 person, 9.09%
Hemiplegia (paralysis of one side of the body): 1 person, 9.09%
Headache (pain in head): 1 person, 9.09%
Cerebral Ischaemia (insufficient blood flow to the brain to meet metabolic demand): 1 person, 9.09%

What are the existing conditions these people have? *

Hiv Infection: 9 people, 81.82%
High Blood Pressure: 4 people, 36.36%
Weakness: 3 people, 27.27%
Dental Caries: 3 people, 27.27%
Depression: 3 people, 27.27%
Dry Skin: 3 people, 27.27%
Gait Disturbance: 3 people, 27.27%
High Blood Cholesterol: 3 people, 27.27%
Insomnia (sleeplessness): 3 people, 27.27%
Pain: 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Maraviroc and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Maraviroc:

Maraviroc (2,653 reports)

Stroke treatments and more:

Stroke (334,635 reports)

Browse all side effects of Maraviroc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,309 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,030 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on maraviroc (the active ingredients of Maraviroc) and Maraviroc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.